Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Response to Comment on "In Vivo [18F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates".

Sander CY, Schoenberger M, Hooker JM.

ACS Chem Neurosci. 2019 Jan 16;10(1):773-775. doi: 10.1021/acschemneuro.8b00423. Epub 2018 Oct 11. No abstract available.


In Vivo [18F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates.

Schoenberger M, Schroeder FA, Placzek MS, Carter RL, Rosen BR, Hooker JM, Sander CY.

ACS Chem Neurosci. 2018 Feb 21;9(2):298-305. doi: 10.1021/acschemneuro.7b00327. Epub 2017 Nov 14.


Functional Characterization of 5-HT1B Receptor Drugs in Nonhuman Primates Using Simultaneous PET-MR.

Hansen HD, Mandeville JB, Sander CY, Hooker JM, Catana C, Rosen BR, Knudsen GM.

J Neurosci. 2017 Nov 1;37(44):10671-10678. doi: 10.1523/JNEUROSCI.1971-17.2017. Epub 2017 Oct 2.


Effects of flow changes on radiotracer binding: Simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation.

Sander CY, Mandeville JB, Wey HY, Catana C, Hooker JM, Rosen BR.

J Cereb Blood Flow Metab. 2019 Jan;39(1):131-146. doi: 10.1177/0271678X17725418. Epub 2017 Aug 17.


News and views on in-vivo imaging of neurotransmission using PET and MRI.

Sander CY, Hesse S.

Q J Nucl Med Mol Imaging. 2017 Dec;61(4):414-428. doi: 10.23736/S1824-4785.17.03019-9. Epub 2017 Jul 27. Review.


A regularized full reference tissue model for PET neuroreceptor mapping.

Mandeville JB, Sander CYM, Wey HY, Hooker JM, Hansen HD, Svarer C, Knudsen GM, Rosen BR.

Neuroimage. 2016 Oct 1;139:405-414. doi: 10.1016/j.neuroimage.2016.06.044. Epub 2016 Jun 27.


Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI.

Sander CY, Hooker JM, Catana C, Rosen BR, Mandeville JB.

Neuropsychopharmacology. 2016 Apr;41(5):1427-36. doi: 10.1038/npp.2015.296. Epub 2015 Sep 21.


A 31-channel MR brain array coil compatible with positron emission tomography.

Sander CY, Keil B, Chonde DB, Rosen BR, Catana C, Wald LL.

Magn Reson Med. 2015 Jun;73(6):2363-75. doi: 10.1002/mrm.25335. Epub 2014 Jul 7.


Dynamic functional imaging of brain glucose utilization using fPET-FDG.

Villien M, Wey HY, Mandeville JB, Catana C, Polimeni JR, Sander CY, Z├╝rcher NR, Chonde DB, Fowler JS, Rosen BR, Hooker JM.

Neuroimage. 2014 Oct 15;100:192-9. doi: 10.1016/j.neuroimage.2014.06.025. Epub 2014 Jun 14.


Evaluation of potential PET imaging probes for the orexin 2 receptors.

Wang C, Wilson CM, Moseley CK, Carlin SM, Hsu S, Arabasz G, Schroeder FA, Sander CY, Hooker JM.

Nucl Med Biol. 2013 Nov;40(8):1000-5. doi: 10.1016/j.nucmedbio.2013.07.001. Epub 2013 Aug 15.


Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI.

Sander CY, Hooker JM, Catana C, Normandin MD, Alpert NM, Knudsen GM, Vanduffel W, Rosen BR, Mandeville JB.

Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11169-74. doi: 10.1073/pnas.1220512110. Epub 2013 May 30.


A receptor-based model for dopamine-induced fMRI signal.

Mandeville JB, Sander CYM, Jenkins BG, Hooker JM, Catana C, Vanduffel W, Alpert NM, Rosen BR, Normandin MD.

Neuroimage. 2013 Jul 15;75:46-57. doi: 10.1016/j.neuroimage.2013.02.036. Epub 2013 Mar 1.

Supplemental Content

Loading ...
Support Center